Bolton Medical Reports Initial Case From Limited Launch of Treo System in Europe

October 16, 2015—Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implantation of the Treo abdominal stent graft system was performed by Theodosios Bisdas, MD, and Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surgery at St. Franciscus Hospital Münster in Münster, Germany. 

In the company’s press release, Prof. Torsello commented, “Treo tracked beautifully through the patient’s anatomy. I had complete deployment control as I was able to make adjustments cranially and caudally prior to final placement. The case was successful at final imaging.”

Bolton Medical began a limited market release of Treo involving selected physicians in Europe with plans for a full launch in January at LINC 2016, the Leipzig Interventional Course.

On September 24, the company announced European CE Mark approval for the Treo device for the endovascular aneurysm repair of abdominal aortic aneurysms.

According to the company, the Treo abdominal stent graft system was designed for long-term stability of the implant in the most challenging anatomies. Dual proximal fixation provides increased resistance to migration forces and the device’s Lock Stent technology provides active fixation between the modular components. The Treo system’s trimodular design, which has a wide range of sizes across all components, allows for precise and controlled deployment with the ability to reposition the stent graft during the procedure.